Clinical trial
Clinical Trial of Teriparatide in Japan
NCT00191867 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00191867 |
|---|---|
| Title | Clinical Trial of Teriparatide in Japan |
| Official title | Assessment of Dose Response of LY333334 in Japanese Postmenopausal Women With Osteoporosis |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Teriparatide |
| Enrollment | 160 |
| Start date | Feb 1, 2005 |
| Completion | Mar 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Nov 6, 2007 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: